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ttp://dx.doi.org/10.1016/j.ajpath.2014.07.006Recent reports of rupture in patients with abdominal aortic aneurysm (AAA) receiving B-cell depletion
therapy highlight the importance of understanding the role of B cells (B1 and B2 subsets) in the devel-
opment of AAA. We hypothesized that B2 cells aggravate experimental aneurysm formation. The IHC
staining revealed inﬁltration of B cells in the aorta of wild-type (C57BL/6) mice at day 7 after elastase
perfusion and persisted through day 21. Quantiﬁcation of immune cell types using ﬂow cytometry at day 14
showed signiﬁcantly greater inﬁltration of mononuclear cells, including B cells (B2: 93% of total B cells) and
T cells in elastase-perfused aortas compared with saline-perfused or normal aortas. muMT (mature B-cell
deﬁcient) mice were prone to AAA formation similar to wild-type mice in two different experimental AAA
models. Contradicting our hypothesis, adoptive transfer of B2 cells suppressed AAA formation (102.0% 
7.3% versus 75.2% 5.5%; P< 0.05) with concomitant increase in the splenic regulatory T cell (0.24%
0.03% versus 0.92% 0.23%; P < 0.05) and decrease in aortic inﬁltration of mononuclear cells. Our data
suggest that B2 cells constitute the largest population of B cells in experimental AAA. Furthermore, B2 cells,
in the absence of other B-cell subsets, increase splenic regulatory T-cell population and suppress AAA
formation. (Am J Pathol 2014, 184: 3130e3141; http://dx.doi.org/10.1016/j.ajpath.2014.07.006)Supported by NIH grant 5K08HL98560 (G.A.).
Disclosures: None declared.Abdominal aortic aneurysms (AAAs) remain a life-threatening
disease. Rupture of AAAs causes acute hemorrhage leading to
shock and death. Moreover, recent reports indicate AAA
rupture in patients receiving rituximab (a commercially
available anti-CD20 antibody) for the treatment of various
autoimmune diseases and B-cell lymphomas.1e3 With no
available nonsurgical therapies to treat AAAs, there is a
pressing need to understand the mechanisms of AAA growth
and rupture. During AAA formation, aortic medial and
adventitial layers undergo major pathological changes, such as
degradation of extracellular matrix and marked inﬁltration of
inﬂammatory cells, such as T cells, B cells, macrophages, mast
cells, neutrophils, natural killer cells, and dendritic cells.4e10
Therefore, understanding the role of the inﬂammatory cells
is crucial to develop a therapy to suppress aneurysm growth.
B cells have long been known to be present in human AAA.
By immunohistochemistry (IHC), an estimated 60% to 80% of
the inﬂammatory inﬁltrate in the adventitia is classiﬁed as B
cells (CD20þ). By using ﬂow cytometry, nearly 20% to 41.1%stigative Pathology.
.of total mononuclear hematopoietic cells (CD45þ) are
considered B cells (CD19þ).4,8 Flow cytometry analysis of
lymphocytes4 in human AAA wall identiﬁed activated mem-
ory B cells with homing properties and expressing activation
markers. The presence of B-cellebound immunoglobulins,
such as IgM and IgG, in human AAA tissue has also been well
documented.4,7,8,11 B cells are known to form lymphoid fol-
licles called vascular-associated lymphoid tissue12,13 with T
cells, which are prominent in AAA. B cells are also detected in
AAA of apolipoprotein Eedeﬁcient mice after 14 days of
angiotensin II infusion.14
Similar to AAA, atherosclerosis is characterized by a chronic
inﬂammatory cell inﬁltrate, including B and T cells.15 Geneti-
cally B-celledeﬁcient mice, muMT, develop atherosclerosis.16
Doran et al17 have reported adoptive transfer of total
B-cell population to muMT mice protected mice against
Protective Role of B2 Cells in AAAatherosclerosis with signiﬁcant decrease in macrophage content
in aortas. Speciﬁc roles for B-cell subsets B1a, B1b, and B2 in
the pathogenesis and progression of atherosclerosis have also
been identiﬁed.16e26 Speciﬁcally, B1a cells appear to be pro-
tective in atherosclerosis via production of natural antibodies
IgM, whereas B2 cells are proatherogenic via activation/pro-
liferation of T cells. As far as role of T cells is concerned, CD4þ
T cells are atherogenic,27 whereas T-regulatory cells (Tregs;
CD4þCD25þFoxp3þ) are atheroprotective.28,29
Although the role of T cells in AAA formation has been
widely investigated,30e35 the role of B cells or B-cell subsets in
AAA remains elusive. We hypothesized that B cells were
necessary for AAA formation, and the largest constituent of B
cells in AAA would be B2 cells. We further hypothesized that
adoptive transfer of B2 cells to a B-celledeﬁcient mouse
would exacerbate AAA formation. We have previously
detected neutrophils, macrophages, and T cells in the murine
aorta at day 3 using a well-established model of aortic elastase
perfusion.36 Because B cells have never been fully charac-
terized in experimental AAA, we ﬁrst examined if B cells are
present in murine AAA and, subsequently, developed a ﬂow
cytometry method to methodically phenotype and quantify
B-cell subsets in AAA. To understand the role of B2 cells, we
adoptively transferred isolated B2 cells to muMT mice and
examined AAA formation. Our study addresses a putative
protective role of B2 cells in experimental AAA.
Materials and Methods
Tissue Collection from Humans
Tissue collection from humans was approved by the Uni-
versity of Virginia (Charlottesville, VA) Institutional Re-
view Board for Health Sciences Research (Institutional
Review Board number 13178). AAA tissues from humans
were collected from patients undergoing open AAA repair.
The tissues collected were immediately rinsed with saline
and stored at 10% formalin. The patient and tissue charac-
teristics are given in Supplemental Table S1.
Mice
C57BL/6 (stock number 000664) and muMT mice on
C57BL/6 background (stock number 002288) were obtained
from Jackson Laboratory (Bar Harbor, ME). Only male
mice were used for induction of AAA or cell isolation. All
protocols were approved by the University of Virginia
Animal Care and Use Committee. All mice were given
water and standard chow diet (catalog number 7012; Teklad
Diets, Madison, WI) ad libitum.
Elastase Perfusion and Topical Model of Mouse AAA
Elastase perfusion model of mouse AAAwas performed using
saline (control) or elastase, as previously described,37,38 and
aortas were harvested at day 0, 3, 7, 14, or 21. A topicalThe American Journal of Pathology - ajp.amjpathol.orgelastase model of mouse AAA was performed as described by
Bhamidipati et al,39 and aortaswere harvested at day 14. Video
micrometry measurements were performed before perfusion,
after perfusion, and at the time of harvest. Changes in aortic
diameter were calculated as percentage dilation over baseline
at day 14.
Phenotyping and Quantiﬁcation of Immune Cells in
AAA Samples
Dilated aortas were carefully collected frommice and digested
with an enzymatic cocktail of 1000 U/mL collagenase type I,
400 U/mL collagenase type XI, 125 U/mL hyaluronidase type
I-s, and 60 U/mL DNase.17 Subsequently, the samples were
stained with ﬂuorescent dyeeconjugated antibodies and run
on the 16-color ﬂow cytometer machine LSRFortessa
(equipped with laser lines 488, 405, 561, and 640 nm; Becton
Dickinson, Franklin Lakes, NJ) located in the Flow Cytometry
Core Facility at University of Virginia. The ﬂow antibodies
used were obtained from BD Pharmingen (San Jose, CA)
[phosphatidylethanolamine (PE) rat anti-mouse Foxp3,MF23]
andBiolegend (SanDiego, CA) (puriﬁed anti-mouseCD16/32,
clone 93; PE/Cy7 anti-mouse CD3ε, clone 145-2C11; allo-
phycocyanin anti-mouse CD4, GK1.5; Alexa Fluor 647 anti-
mouse CD5, 53-7.3; PerCP/Cy5.5 anti-mouse CD19, 6D5;
PE anti-mouse CD23, B3B4; allophycocyanin/Cy7 anti-
mouse CD45, 30-F11; Alexa Fluor 488 anti-mouse/human
CD45R/B220, RA3-6B2; and PE anti-mouse IgM, RMM-
1). Dead cells were eliminated from analysis by staining
with DAPI (Sigma-Aldrich, St. Louis, MO) or LIVE/DEAD
Fixable Dead Cell Stain Kit from Molecular Probes, Invi-
trogen (Eugene, OR). For Foxp3 staining, surface-stained
cells were ﬁxed with 4% paraformaldehyde and per-
meabilized with 0.5% saponin. The ﬂow data were analyzed
using FlowJo software. To count the number of cells,
CountBright Absolute Counting Beads (Molecular Probes,
Grand Island, NY) were added to the cell suspension before
ﬂow cytometry. Fluorescent minus one controls were used
for each antibody in the experiment.
To quantify intracellular cytokines, isolated B cells were
ﬁrst stained with live/dead cell stain, then surface stained with
PE/Cy7 anti-mouse CD19 (6D5; Biolegend), ﬁxed, and per-
meabilized with saponin. Intracellular cytokines were stained
with antibodies from eBiosciences (San Diego, CA) (anti-
mouse IL-6 PE, MP5-20F3) and Biolegend [Alexa Fluor 700
anti-mouse IL-2, JES6-5H4; Alexa Flour 647 anti-mouse IL-4,
1B11; PerCP/Cy5.5 anti-mouse IL-10, JES5-16E3; and Alexa
Fluor 488 anti-mouse interferon (IFN)-g, XMG1.2], and
counting beads were added before running on LSRFortessa.
IHC Data
Standard immunoperoxidase or immunoﬂuorescence staining
methods were performed on parafﬁn sections (5 mm thick) of
human or mouse AAA. In human sections, B cells were
detected using anti-CD79a antibody (HM47/A9; Abcam,3131
Figure 1 Presence of B and T cells in the aortic wall of human and mouse AAA. A:
Left: Human AAA section stained with B cells (CD79a, brown). Right: A consecutive
section stained for both B cells (CD79a, green) and T cells (CD3ε, red); image was ac-
quired on a confocal microscope. B: Mouse aortic sections from day 0, 3, 7, 14, and 21
after elastase perfusion stained for B cells (B220, brown) (nZ 3). C: Mouse aortic section
from 14 days after elastase perfusion stained for B cells (B220, green) and T cells (CD3ε,
red); image was acquired on an epiﬂuorescent microscope. The asterisk indicates lumen.
Scale bars: 500 mm (A, left); 10 mm (A, right); 50 mm (B and C).
Meher et alCambridge, MA) and T cells using anti-CD3 antibody (SP7;
Abcam). In mouse aortic sections, B cells were detected using
rat anti-mouse CD45R (RA3-6B2; BD Pharmingen, San Jose,
CA), T cells using anti-CD3 antibody (sc-1127; Santa Cruz
Biotechnology, Inc., Dallas, TX), macrophages using antie
Mac-2 antibody (Cedarlane, Burlington, NC), and neutrophils
using rat anti-mouse Ly-6B.2 antibody (AbD Serotec,
Kidlington, UK). Immunoperoxidase and epiﬂuorescent im-
ages were acquired on a Nikon Eclipse TieU inverted mi-
croscope (Melville, NY) and NIS-Elements Br microscope
imaging software. Confocal images were acquired on Zeiss
LSM 700 (Peabody, MA) using 405-, 488-, and 633-nm lasers
and ZEN 2012 lite software (Zeiss).3132Isolation of B2 Cell
B2 cells were prepared from spleen of 8- to 10-week-old
wild-type (WT) mice. Brieﬂy, mice were euthanized by
CO2 inhalation, followed by cervical dislocation. Spleens
were collected, and a single-cell suspension was prepared
by passing through a 70-mm mesh. Red blood cells were
lysed and B2 cells were isolated using CD43 (ly-48)
microbeads (130-049-801) from Miltenyi Biotec (Auburn,
CA) using negative selection strategy as the recom-
mended protocol. Soon after isolation, B2 cells were
suspended in phosphate-buffered saline (PBS) and trans-
ferred to muMT mice.ajp.amjpathol.org - The American Journal of Pathology
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AAA was induced in WT mice using an elastase perfusion
method. For controls, aortas were perfused with saline. Day 14
after perfusion, aortas were harvested as described before. Two
elastase- or saline-perfused aortas were pulled together and
digested with the aorta-digesting enzymes. Thereafter, the cell
suspension was washed with PBS and untouched pan B cells
were isolated using pan B cell isolation kit (130-095-813; Mil-
tenyi Biotec, San Diego, CA) using the recommended protocol.
Immediately after puriﬁcation, the cells were washed and sus-
pended in B-cell medium [Iscove’s modiﬁed Dulbecco’s me-
dium supplementedwith 1mmol/L sodium pyruvate, 2mmol/L
L-glutamine, 55 mmol/L b-mercaptoethanol, 0.1 mg/mL bovine
serum albumin, and 1% antibiotic-antimycotic (Gibco, Grand
Island,NY)] and incubated at 37C.Two hours after incubation,
the aortic B cells were cultured for a further 18 hours with 5 ng/
mL phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich),
calcium ionophore A23187, or 1.25 mmol/L ionomycin
(Sigma-Aldrich) and 10 mg/mL brefeldin A (Sigma-Aldrich)
and intracellular cytokines, which were quantiﬁed on a ﬂow
cytometer, as described earlier in Materials and Methods.B-Cell Transfer and Induction of AAA
Seven-week-old muMT male littermates were transferred with
25 million of isolated B2 cells or PBS via tail vein, and AAAFigure 2 A: Schematic shows a segment of dilated aorta harvested for phenot
phenotype B cells from day 14 elastase-perfused aorta. C: Representative ﬂow p
perfused aorta. FSC, forward scatter; IVC, inferior vena cava; SSC, side scatter.
The American Journal of Pathology - ajp.amjpathol.orgwas induced using elastase perfusion model after 7 days.
Fourteen days after elastase perfusion, mice were harvested.
Statistical Analysis
Means and SEMs were calculated using GraphPad Prism
version 5 (La Jolla, CA). An unpaired nonparametric t-test was
used to determine differences between two groups, whereas
multiple groups were compared using a simple one-way
analysis of variance. P < 0.05 was considered signiﬁcant.
Results
B and T Cells Colocalize in Human AAA
We performed double-immunoﬂuorescence staining to
examine the abundance and localization of both B (anti-
CD79a) and T (anti-CD3ε) cells in human AAA wall
(Figure 1A). Both B and T cells were abundant and con-
tacted each other, forming lymphoid-like structures in the
aortic media of AAA. VerhoeffeVan Gieson (VVG) and
a-smooth muscle actin staining revealed absence of
thrombus in AAA wall (Supplemental Figure S1, A and B).
B Cells in Experimental AAA
To determine whether B cells are present in experimental
models of mouse AAA, we induced AAA by elastase perfusionypic analysis of B cells. B: Representative ﬂow plots and gating strategy to
lots (already gated for lymphocytes, live and singlets) from day 14 saline-
3133
Figure 3 Increased inﬁltration of immune cells after saline or elastase
perfusion of abdominal aorta of WT mice. Increase in aorta diameter and
quantiﬁcation of the number of immune cells in day 14 saline (nZ 6) and
elastase (n Z 11) perfused aortas, and equivalent length of unperfused
abdominal aorta (n Z 6) from WT mice. Values are expressed as
means  SEM. *P < 0.05, **P < 0.01, and ***P < 0.001, respectively.
Meher et alin WTmice and harvested the aortas at days 0, 3, 7, 14, and 21.
Staining for CD45R/B220, a marker for B cells, demonstrated
appearance of B cells at day 7, which persisted at day 21 in the
adventitial layer (Figure 1B and Supplemental Figure S1C).
Similar to the human AAA samples, we observed B and T cells
are present together at day 14 (Figure 1C). To avoid model-
speciﬁc effects, we used an alternate AAA model, which we
recently described (using full-strength elastase placed adventi-
tially on WT mice39), and observed similar accumulation of B
cells at day 14 (data not shown). Altogether, our results
demonstrate prevalence of B cells in experimental models of
mouse AAA.
Characterization of B-Cell Subsets in Mouse AAA
Next, we developed a unique method to perform ﬂow
cytometry on individual mouse AAAs to quantify B-cell
subsets. Our optimized protocol for digestion allowed us to
prepare a cell suspension from an approximately 5-mm
segment of abdominal aorta (Figure 2A) from mouse. Un-
expectedly, we observed that surface expression of CD23, a
well-studied marker for B-cell phenotyping, was abolished
(Supplemental Figure S2A) in our optimized protocol and in
the protocol described by Butcher et al.40 Therefore, we
followed the gating strategy, as described by Thomas et al,41
which uses the markers CD19 and B220 to determine the B1
and B2 cell populations. In our gating strategy (Figure 2B),
lymphocytes were gated ﬁrst, followed by live cells, sin-
glets, CD45þCD3 mononuclear hematopoietic cells, and B
cells (CD19þB220þ). CD19hiB220lo cells were considered
B1 cells, whereas CD19loB220hi cells were considered B2
cells. Furthermore, B1-gated cells were phenotyped as B1a
(CD19hiCD5hi) and B1b (CD19hiCD5lo) cells. All B cells
were found to express IgM (data not shown). We further
observed that our surgical procedure, which involved lapa-
rotomy of mouse to perform saline or elastase perfusion of
abdominal aorta, led to a decrease in B1 cell population
(from 46% to 13%) and an increase in B2 cell population
(from 21% to 49%) of total hematopoietic cells in peritoneal
ﬂuid (Supplemental Figure S2B). However, the populations
of B-cell subsets in spleen and blood were unaffected after
surgery (data not shown).
B2 Cells Are the Largest Constituent of B Cells in Mouse
AAA
We used counting beads in ﬂow cytometry to determine the
number of immune cells in unperfused normal abdominal
aorta, and saline- and elastase-perfused aortas of WT mice.
Elastase perfusion led to AAA formation in WT mice
(Figure 3). Few immune cells were detected in the normal
aorta, whereas the numbers of mononuclear hematopoietic
cells, T cells, B cells, and B-cell subsets were signiﬁcantly
higher in elastase-perfused aortas compared with the saline-
perfused aortas (Figure 3). In elastase-perfused aortas, 23%
of mononuclear inﬁltrates were T cells, whereas 4.5% were3134B cells. B-cell numbers were 3631  578 and 1476  524
in elastase- and saline-perfused aortas, respectively. B2 cells
were the largest constituent of B cells, both in elastase (B1
versus B2, 7.2% versus 92.8% of total B cell) and saline (B1
versus B2, 3.7% versus 96.3% of total B cell) perfused
aortas (Figures 2, B and C, and 3). Among the B1 cell
subsets, B1b cell number was higher than B1a cell. Corre-
lation analysis between the immune cell number aorta
diameters (irrespective of elastase or saline perfusion)
revealed that total hematopoietic cell, T cell, B1, B1a, and
B1b cell counts strongly correlated with increasing aorta
diameter (Supplemental Figure S3). However, total B and
B2 cell counts poorly correlated with aortic diameter.
Because B2 cells were the largest constituent of B cells, B2
cell number affected correlation of total B cell with aorta
diameter. Altogether, our data showed that elastaseajp.amjpathol.org - The American Journal of Pathology
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cells compared with saline-perfused or normal aortas, and
many B cells are B2 cells; however, it is undeﬁned whether
B2 cells are protective or harmful.
B Cells from Saline- and Elastase-Perfused Aortas Have
a Similar Cytokine Secretion Proﬁle
Cytokine-producing effector B cells (Be) have been shown to
regulate many inﬂammatory diseases, which are independent
of antibodies produced by B cells.42 Harris et al43 divided Be
cells into two subsets: Be1 cells that synthesize tumor ne-
crosis factor-a, IFN-g, and IL-12, and Be2 cells that syn-
thesize IL-2, IL-4, IL-6, and IL-10. To determine the Be cell
types present in saline- and elastase-perfused aortas, we pu-
riﬁed total B cells using magnetic-activated cell sorting
(MACS) columns (Figure 4A) stimulated with a mixture of
PMA and ionomycin, blocked cytokine secretion using bre-
feldin A, and examined intracellular synthesis of IFN-g, IL-
2, IL-4, IL-6, and IL-10 using ﬂow cytometry. We found a
large population of B cells synthesized IL-6 and IL-10,
indicating predominance of Be2 cell type; however, no dif-
ference was observed between these populations of B cells
isolated from saline- and elastase-perfused mice (Figure 4B).
This suggests that the B cells inﬁltrated to the aorta have
similar Be populations irrespective of saline or elastase
perfusion. However, more B cells in elastase-perfused aorta
compared with saline-perfused aorta suggests a higher level
of Be cytokines in the aneurysms.
B-Cell Deﬁciency Cannot Protect Mice from
Experimental AAA
muMT mice are deﬁcient in mature B1 and B2 cells. To
understand the role of B cell in AAA formation, we induced
AAA in muMT mice using the elastase perfusion model. To
our surprise, we observed muMT mice developed AAA
similar to the WT mice at day 14 (Figure 5A). Histo-
chemical staining on aortic cross sections revealed increased
collagen degradation (VVG) and abundance of T cells,Figure 4 Cytokines synthesized by B cells. A: Elastase- or saline-perfused aort
isolated using Miltenyi column. B: The isolated aortic B cells were cultured for 18 h
and then stained with live/dead dye and B cell surface marker (CD19). Subseq
cytokines, which were quantiﬁed on a ﬂow cytometer. B cells isolated from two a
The American Journal of Pathology - ajp.amjpathol.orgmacrophages, and neutrophils (Figure 5A), which were also
found in day 14 WT mice (Supplemental Figure S4). Our
ﬁndings contradict a study by Zhou et al,44 who reported
that muMT mice were protected from AAA by elastase
perfusion. Therefore, to further conﬁrm our ﬁndings, we
studied the effect of B-cell deﬁciency using a second
experimental AAA model. Speciﬁcally, we observed that
both WT and muMT mice developed AAA at day 14 using
a novel topical elastase model that we reported previously39
(Figure 5B). The IHC staining of aortic sections from
muMT mice further demonstrated abundance of T cells,
macrophages, and neutrophils (Figure 5B), similar to day 14
WT mice (Supplemental Figure S4). These results suggest
that in the absence of B cells, other immune cells, such as
neutrophils, macrophages, and T cells, potentially regulate
aneurysm formation in muMT mice.
Adoptive Transfer of B2 Cells Suppresses AAA Growth
and Increases Peripheral Treg Population in muMT Mice
Because the muMT mice developed an aneurysm similar to
WT mice, we speculated that B1 and B2 cells have opposing
roles in AAA formation, as they do in atherosclerosis.
Adoptive transfer of total spleen cells or splenic B cells has
been shown to protect mice from development of athero-
sclerosis.26 Because B2 cells worsen experimental athero-
sclerosis, we hypothesized that adoptive transfer of B2 cells
would worsen aneurysm formation in muMT mice. There-
fore, we adoptively transferred 25 million MACS column
puriﬁed (purity >98%) (Supplemental Figure S5) splenic
B2 cells in PBS to muMT mice. As described in experi-
mental atherosclerosis studies,19 control muMT mice were
injected with an equal volume of PBS. Transfer of isolated
B2 cells reconstituted 8.8  1.6  105 B2 cells in the spleen
of muMT mice (Figure 6, A and B). This led to a 2.2-fold
increase in T cell and a twofold increase in the number of
mononuclear hematopoietic cells in spleen (Figure 6, C and
D). Contrary to our hypothesis, the aneurysm size was
signiﬁcantly smaller in B2 celletransferred mice compared
with PBS controls (75.2%  5.5% in B2 celletransferredas were collected at day 14 and digested, and untouched total B cells were
ours with 5 ng/mL PMA, 1.25 mmol/L ionomycin, and 10 mg/mL brefeldin A
uently, the cells were ﬁxed, permeabilized, and stained for intracellular
ortas were pooled to make n Z 4. Values are expressed as means  SEM.
3135
Figure 5 muMT mice develop AAA with increased elastin degradation and increased inﬁltration of immune cells to aorta. muMT mice develop AAA
similar to WT mice in elastase perfusion (A; n Z 8 to 10) and topical elastase (B; n Z 6 to 8) model. AAA sections from muMT mice were stained for
VVG (elastic ﬁbers, black), T cells (CD3ε, brown), macrophages (Mac2, brown) and neutrophils (Gr1, brown). Values are expressed as means  SEM. There
is no signiﬁcant difference in AAA growth between WT/elastase and muMT/elastase animals in elastase perfusion or topical elastase model. ***P <
0.001. Scale bar Z 50 mm (A and B).
Meher et almuMT versus 102.0%  7.3% in control muMT, PZ 0.01)
(Figure 6E). In accordance with decreased AAA size, the
number of mononuclear hematopoietic cells and T cells
trended lower in the elastase-perfused aortas of B2 celle
transferred mice (Supplemental Figure S6), although it did
not reach to a level of statistical signiﬁcance. This suggests
adoptive transfer of B2 celleinduced generation or differ-
entiation of a protective cell type.
B2 cells have been shown to promote differentiation of
naïve CD4 T cells to Tregs. Therefore, we determined
Treg population (CD45þCD3εþCD4þFoxp3þ) in the3136spleen, draining lymph nodes, peritoneal ﬂuid, and
aneurysm tissues of these mice using ﬂow cytometry. The
B2 celletransferred muMT mice showed an increased
percentage (% of total CD3εþ T cells), 0.24%  0.03%
versus 0.92%  0.23% (P Z 0.02), as well as total
number (PZ 0.01) of Tregs in spleen (Figure 6, F and G).
The percentage of Tregs in inﬁltrated T cells trended to be
increased in B2 celletransferred aorta (Supplemental
Figure S6); however, we did not observe signiﬁcant dif-
ferences in Treg population in lymph nodes or peritoneal
ﬂuids. The observed increase in Treg population in theajp.amjpathol.org - The American Journal of Pathology
Figure 6 Adoptive transfer of B2 cells suppressed AAA formation and increased peripheral Treg population in muMT mice. A: Representative ﬂow plots
show reconstitution of B2 cells in spleen of muMT mice transferred with 25 million WT B2 cells. Increase in absolute numbers of B2 (B), T (C), and mononuclear
hematopoietic (D) cells in spleen of muMT mice (nZ 5) transferred with B2 cells. E: Increase in aorta diameter in PBS or B2 celletransferred mice (nZ 7 to
9). F: Representative ﬂow plots show increased Treg (CD4þFoxp3þ) population in B2 celletransferred mice. G: Increase in Treg population in spleen of muMT
mice (n Z 5) transferred with B2 cells. Values are expressed as means  SEM. *P < 0.05, **P < 0.01, and ***P < 0.001, respectively.
Protective Role of B2 Cells in AAAmuMT mice might be originated from the contaminating
Treg in B2 cell preparation. Therefore, we examined our
B2 cell preparation for the presence of Tregs. We did not
ﬁnd contaminating Tregs in isolated B2 cell preparationsThe American Journal of Pathology - ajp.amjpathol.orgthat were being transferred to the muMT mice
(Supplemental Figure S5). These results altogether
showed that adoptive transfer of isolated B2 cells to
muMT mice suppressed aneurysm formation with a3137
Meher et alconcomitant increase in peripheral Tregs and a decrease in
aortic inﬁltration of immune cells.
Discussion
The role of B cells in AAA formation has been poorly
understood. By using a mouse elastase perfusion-induced
AAA, we ﬁrst determined the location and phenotype of the
B cells. We observed that B and T cells colocalized in
human and mouse AAA and that the B2 cell population was
signiﬁcantly higher than B1 cells. By using two models of
experimental AAA, we observed that the muMT mice are
not protected from AAA and appear similar to the WT mice.
Unexpectedly, adoptive transfer of B2 cells into muMT
mice suppressed AAA and was associated with an increase
in peripheral Treg cells.
B cells derived from spleen regulate experimental athero-
sclerosis.19 In atherosclerosis, B2 cells are considered harmful
via activation/proliferation of T cells. However, in vitro, B2
cells promote Treg generation from naïve CD4þ T cells in the
presence of transforming growth factor (TGF)-b and IL-2.45
Moreover, resting B cells expand the Treg population via
producing TGF-b3.46 Others have also shown that splenic B
cells proliferate splenic Tregs in the presence of soluble anti-
CD3 and irradiated splenic antigen-presenting cells.47
Furthermore, B-cell depletion by anti-CD20 antibody led to
encephalomyelitis with concomitant signiﬁcant reduction in
peripheral Tregs.47 In these studies, the B-celledepleted mice
have a normal thymic Treg content,45e47 indicating a domi-
nant role of B-cellemediated generation of peripheral Tregs in
immunosuppression. Consistent with a decreased Treg popu-
lation in B-cell depletion studies, muMT mice were found to
have signiﬁcantly fewer peripheral Tregs compared with WT
mice. A B-cellemediated increase in Treg population was
found to be independent of B-cell production of IL-10. Alto-
gether, there are several lines of evidence that splenic B cells
can increase Treg population either by differentiating naïve
CD4 T cells to Tregs, expanding the existing population of
Tregs, or recruiting Tregs to lymphoid organs. Moreover,
these ﬁndings support our observation that adoptive transfer of
B2 cells increases the splenic Treg population in muMTmice.
Furthermore, TGF-b activity, which is required for Treg ho-
meostasis, has been shown to protectWTmice fromAAA, and
neutralization of TGF-b using antieTGF-b antibody led to
development of aortic aneurysm.48
Both atherosclerosis and AAA are aortic diseases, and
may share common risk factors, such as smoking, hyper-
tension, and obesity.49,50 It is not clear whether atheroscle-
rosis leads to AAA formation or vice versa. In the Tromsø
(Norway) study, lack of consistent dose-response relation-
ship between atherosclerosis and AAA suggests athero-
sclerosis may develop concomitantly with AAA or
secondary to AAA growth.50 Moreover, diabetes is posi-
tively associated with atherosclerosis, but negatively asso-
ciated with AAA, which contradicts the consensus that
AAA is a manifestation of atherosclerosis.513138Tregs have been shown to play an important role in
suppression of atherogenesis in mice.29 It has also been
shown that depletion of Foxp3þ Tregs promotes athero-
sclerosis in mice.28 As far as human AAA is concerned, Yin
et al52 found that the population of CD4þCD25þFoxp3þ
Tregs was signiﬁcantly lower in the peripheral blood of
patients with AAA compared with patients with abdominal
aortic atherosclerotic occlusive disease or healthy controls.
Ait-Oufella et al53 reported that both genetic and anti-CD25
antibody-mediated depletion of Tregs augmented angiotensin
IIeinduced aneurysm formation, and supplementing geneti-
cally Treg-deﬁcient micewithWTTregs suppressed aneurysm
formation. Although anti-CD25 antibody treatment causes a
small decrease in peripheral Treg population (not the natural
Treg content of thymus), it signiﬁcantly affects host immune
response.54 Because B2 cells differentiate naïve CD4þ T cells
to Tregs to a greater frequency than dendritic cells,45 a po-
tential mechanism for B2-induced suppression of AAA in
muMT mice would be Tregs differentiated or expanded in
lymphoid organs, such as spleen, suppress inﬂammation sys-
temically, leading to inhibition of AAA growth. Alternatively,
B2 celleinduced newly differentiated Tregs are recruited to
the site of AAA and prevent aneurysm growth. In fact, our
studies demonstrate increased population of Tregs in the
spleen of muMT mice after B2 cell transfer.
We found the total B cell isolated from saline- or elastase-
perfused aortas produced both proinﬂammatory (IFN-g and
IL-6) and anti-inﬂammatory (IL-2, IL-4, and IL-10) cyto-
kines. B1 cells are well known to produce natural IgM and
protect mice from atherogenesis. In vitro, in contrast to the
effect of B2 cells, B1 cells promote the differentiation of
proinﬂammatory type 1 helper T cell (Th1) and Th17 from
naïve CD4þ T cells with a greater frequency than dendritic
cells.45 Although B1 cells are fewer than B2 cells, they have
greater potency of differentiating Th17 than B2 cells
differentiating Tregs. As far as regulation of T-cell pheno-
type is concerned, the effects of B1 and B2 may counteract
each other via Th17 and Treg in WT mice.
There are several limitations to our study. In most of the
studies involving AAA patients, B cells constitute a large per-
centage of mononuclear cell inﬁltrate. However, in the elastase
perfusion model, we found the percentage of hematopoietic
cells that were B cells (CD45þCD3CD19þB220þ) was only
4.5%. A plausible explanation for this is most of the human
AAA samples were in late stages of aneurysm growth, which
might have taken years to develop. On the other hand, elastase
perfusion is a rapid model and it takes approximately 14 days
for aneurysm development. Nevertheless, this model has been
documented to recapitulate human AAA development55,56 and
widely used for experimental AAA studies. Furthermore, B-cell
populations are identiﬁed by differentmarkers and differ greatly
between mice and humans.57,58
To understand the role of B cells in aneurysm formation, we
performed elastase perfusioneinduced AAA in muMT mice
and found that the muMT mice developed AAA similar to the
WT mice. In accordance with this ﬁnding, a 62-year-oldajp.amjpathol.org - The American Journal of Pathology
Protective Role of B2 Cells in AAApatient with a history of non-Hodgkin lymphoma receiving
rituximab had ruptured AAA,2 whereas patients with immune
cytopenia or spondyloarthropathies died after receiving rit-
uximab treatment.1,3 In contrast to our ﬁndings, Zhau et al44
have reported that muMT mice were protected from elastase
perfusioneinduced AAA and the absence of humoral immune
response (IgG or IgM antibody) was attributed to the protec-
tion. Supplementing the muMTmice with total IgG antibodies
or natural IgM antibodies inducedAAA formation. To conﬁrm
our observation that muMT mice are susceptible to experi-
mental AAA, we used a second model of AAA (topical elas-
tase model developed in our laboratory)39 and still found no
protection inAAA inmuMTmice. Overall, formation of AAA
in muMT mice emphasizes dominance of other immune cells,
such as neutrophils, macrophages, and T cells in AAA in
absence of B cells.
Increasing B2 cells in the spleen of muMT mice via
adoptive transfer can increase Treg population by differen-
tiating CD4þ T cell, expanding the population of existing
Tregs, or both. Further experimentation needs to be done to
delineate the mechanism of B2 cellemediated increase in
Treg population. We observed that adoptive transfer of B2
cells not only increased splenic B2 and Treg populations,
but it also increased total hematopoietic and T-cell popu-
lation. Among the T-cell population, Tregs comprised only
0.9%. Therefore, the presence of other splenic T-cell sub-
populations, such as Th1, Th2, and Th17, in spleen of B2
celletransferred muMT mice needs to be determined.
Furthermore, it is unknown how splenic Treg content reg-
ulates AAA formation. It is possible that adoptively trans-
ferred B2 cells may be synthesizing protective antibodies.
Although the potent immunosuppressive effects of Tregs
can be used in the treatment of multiple inﬂammatory dis-
eases, the scarce availability and unspeciﬁc immune
response generate major obstacles in using autologous Treg
cells as a means of treatment of AAA. Thus, various
methods of Treg generation have been tested, including
dendritic celleinduced Treg differentiation.59 Because B2
cells modulate Treg differentiation from naïve CD4þ T cells
at a greater frequency than dendritic cells, increasing B2 cell
number may represent an alternative and effective approach
to increase Treg number and prevent AAA growth.
Altogether, we have shown that both B1 and B2 cells are
present in mouse experimental AAA, with signiﬁcantly
more B2 than B1 cells. Absence of total B cells does not
affect aneurysm formation; however, adoptive transfer of
isolated B2 cells can suppress AAA progression, with an
increase in peripheral Treg population. Our study has
highlighted a possible protective role of B2 cells in vascular
diseases.Acknowledgments
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